ABBV-CLS-484

· Calico Life Sciences LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABBV-CLS-484, covering 2025-12-23 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors [Phase 1]